We are live on ! Find out more
Simplify Asset Management

Simplify Asset Management Portfolio holdings

AUM $7.19B Turnover 25.77%
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$7.19B
AUM Growth
+$670M
Cap. Flow
+$436M
Cap. Flow %
6.07%
Top 10 Hldgs %
91.65%
Holding
163
New
20
Increased
70
Reduced
37
Closed
22
Avg Time Held Equity + Options
1.2 years
Top 10 Avg Time Held Equity + Options
1.5 years
Top 20 Avg Time Held Equity + Options
1.2 years
Avg Time Held Equity only
1.2 years
Top 10 Avg Time Held Equity only
1.7 years
Top 20 Avg Time Held Equity only
1.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.55%
2 Healthcare 5.05%
3 Energy 0.44%
4 Industrials 0.38%
5 Technology 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IRWD icon
151
Ironwood Pharmaceuticals
IRWD
$595M
– –
-11,447
Closed -$40.2K –
MMM icon
152
3M
MMM
$87.8B
– –
-44,241
Closed -$6.43M –
OCS icon
153
Oculis Holding
OCS
$478M
– –
-66,667
Closed -$1.77M –
OVID icon
154
Ovid Therapeutics
OVID
$471M
– –
-130,813
Closed -$290K –
OXLC icon
155
Oxford Lane Capital
OXLC
$754M
– –
-100,000
Closed -$978K –
PANW icon
156
Palo Alto Networks
PANW
$280B
– –
-3,967
Closed -$636K –
PEP icon
157
PepsiCo
PEP
$183B
– –
-1,305
Closed -$203K –
REGN icon
158
Regeneron Pharmaceuticals
REGN
$82.2B
– –
-10,900
Closed -$8.42M –
TRVI icon
159
Trevi Therapeutics
TRVI
$1.78B
– –
-65,412
Closed -$780K –
VOR icon
160
Vor Biopharma
VOR
$1.12B
– –
-53,510
Closed -$955K –
VRDN icon
161
Viridian Therapeutics
VRDN
$2.47B
– –
-56,231
Closed -$1.1M –
KLRS icon
162
Kalaris Therapeutics
KLRS
$47.4M
– –
-87,426
Closed -$504K –
SAFX icon
163
XCF Global Inc
SAFX
$65.8M
– –
-188,857
Closed -$69K –

Similar funds

Simplify Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Simplify Asset Management held 163 positions worth $7.19B, up 10% from $6.52B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Simplify Asset Management deployed $436M of net new capital in Q2 2026, opening 20 new positions and adding to 70 existing holdings. Its largest new stake was Simplify China A Shares PLUS Income ETF: 428,078 shares worth $12.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 95% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $36.1M trimmed.

  • Simplify Asset Management's largest Q2 2026 buy was Simplify China A Shares PLUS Income ETF: 428,078 shares worth $12.4M.
  • Simplify Asset Management added most to Simplify Government Money Market ETF in Q2 2026, an estimated $311M increase.
  • Simplify Asset Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $36.1M.
  • Simplify Asset Management fully exited Regeneron Pharmaceuticals in Q2 2026, selling an estimated $8.42M.
  • Simplify Asset Management's ten largest holdings make up 92% of its $7.19B portfolio in Q2 2026.
  • Simplify Asset Management opened 20 new positions and closed 22 in Q2 2026.
  • Simplify Asset Management's portfolio value rose 10% quarter-over-quarter to $7.19B.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.